These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2237923)

  • 1. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Pohjanvirta R; Tuomisto J
    Toxicol Appl Pharmacol; 1990 Sep; 105(3):508-9. PubMed ID: 2237923
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57B1/6 mice.
    Vos JG; Moore JA; Zinkl JG
    Toxicol Appl Pharmacol; 1974 Aug; 29(2):229-41. PubMed ID: 4283688
    [No Abstract]   [Full Text] [Related]  

  • 3. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal absorption of nutrients in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Ball LM; Chhabra RS
    J Toxicol Environ Health; 1981 Oct; 8(4):629-38. PubMed ID: 7338935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexadecane increases the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): is brown adipose tissue the primary target in TCDD-induced wasting syndrome?
    Rozman K
    Biochem Biophys Res Commun; 1984 Dec; 125(3):996-1004. PubMed ID: 6517950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
    Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
    Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): results of a 13-week oral toxicity study in rats.
    Kociba RJ; Keeler PA; Park CN; Gehring PJ
    Toxicol Appl Pharmacol; 1976 Mar; 35(3):553-74. PubMed ID: 1265768
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in four (sub)strains of adult male rats.
    Walden R; Schiller CM
    Toxicol Appl Pharmacol; 1985 Mar; 77(3):490-5. PubMed ID: 3975916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice.
    Chapman DE; Schiller CM
    Toxicol Appl Pharmacol; 1985 Mar; 78(1):147-57. PubMed ID: 4035666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD); "dioxin".
    Rep Carcinog; 2004; 11():III241-3. PubMed ID: 21089963
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for the induction of an oxidative stress in rat hepatic mitochondria by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Stohs SJ; Alsharif NZ; Shara MA; al-Bayati ZA; Wahba ZZ
    Adv Exp Med Biol; 1991; 283():827-31. PubMed ID: 2069063
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a sublethal dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on interscapular brown adipose tissue of rats.
    Rozman K; Pereira D; Iatropoulos MJ
    Toxicol Pathol; 1987; 15(4):425-30. PubMed ID: 3432942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Han/Wistar rats are exceptionally resistant to TCDD. II.
    Pohjanvirta R; Tuomisto J
    Arch Toxicol Suppl; 1987; 11():344-7. PubMed ID: 3477197
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationships and dose responses of polychlorinated dibenzo-p-dioxins for short-term effects in 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant and -sensitive rat strains.
    Simanainen U; Tuomisto JT; Tuomisto J; Viluksela M
    Toxicol Appl Pharmacol; 2002 May; 181(1):38-47. PubMed ID: 12030841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunotoxicity.
    Pazdernik TL; Rozman KK
    Life Sci; 1985 Feb; 36(7):695-703. PubMed ID: 3881642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on plasma and tissue beta-endorphin-like immunoreactivity in the most TCDD-susceptible and the most TCDD-resistant rat strain.
    Pohjanvirta R; Unkila M; Tuomisto JT; Vuolteenaho O; Leppäluoto J; Tuomisto J
    Life Sci; 1993; 53(19):1479-87. PubMed ID: 8412511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice.
    Weber LW; Lebofsky M; Stahl BU; Smith S; Rozman KK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):155-62. PubMed ID: 7878671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent influence of neonatal 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment on glucocorticoid receptors and on the microsomal enzyme system.
    Csaba G; Mag O; Inczefi-Gonda A; Szeberenyi S
    J Dev Physiol; 1991 Jun; 15(6):337-40. PubMed ID: 1661310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Ah-receptor levels and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hepatic microsomal monooxygenase activities in a TCDD-susceptible and -resistant rat strain.
    Pohjanvirta R; Juvonen R; Kärenlampi S; Raunio H; Tuomisto J
    Toxicol Appl Pharmacol; 1988 Jan; 92(1):131-40. PubMed ID: 2829388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical view of the mechanism(s) of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Implications for human safety assessment.
    Rozman K
    Derm Beruf Umwelt; 1989; 37(3):81-92. PubMed ID: 2663408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.